Previous investigators have extensively described the clinical characteristics of patients diagnosed with PAH who carry BMPR2 variants or PVOD/PCH who carry biallelic EIF2AK4 variants in European and American populations, but Chinese populations are not well represented in these reports [12, 13]. Here, EIF2AK4 is linked to pulmonary venoocclusive disease.